Evolving Evidence in Idiopathic Intracranial Hypertension
- PMID: 34833101
- PMCID: PMC8619700
- DOI: 10.3390/life11111225
Evolving Evidence in Idiopathic Intracranial Hypertension
Abstract
Idiopathic intracranial hypertension (IIH) is an enigmatic disorder characterized by raised intracranial pressure (ICP) with no known cause and it affects both children and adults [...].
Conflict of interest statement
Mollan has received consulting fees from Invex Therapeutics, and Honoria for speaking from Heidelberg engineering during the conduct of the study; and Honoria from Chugai-Roche Ltd., Janssen, Allergan Santen, Roche, and Neurodiem, outside the submitted work. The remaining authors have no financial relationships relevant to this article to disclose.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
